文献速递免疫规划

商业猪圆环病毒(PCV)2a型疫苗减少PCV2d病毒血症和排毒并阻止PCV2d传播至未感染猪的实验条件下研究

A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naïve pigs under experimental conditions.
PubMed 文献 · Vaccine · 2016-12-02

研究将38头猪随机分为四组,评估商业灭活PCV2a疫苗Circovac®对2013年PCV2d株实验攻击的保护效果。接种显著降低PCV2d病毒血症、粪鼻排毒和淋巴结抗原载量,并减少传播至未感染猪。作者认为PCV2a疫苗对PCV2d感染猪群应有效。

要点

  • PCV2a疫苗接种显著降低PCV2d攻击后的病毒血症和粪鼻排毒。
  • 疫苗接种显著降低淋巴结PCV2抗原载量。
  • pooled粪便来自CHAL猪含感染性PCV2,而VAC+CHAL猪则无,提示减少传播。

核心结论

  • 在研究条件下,PCV2a基础疫苗有效减少PCV2d病毒血症、组织载量、排毒和传播,表明PCV2a疫苗接种应在PCV2d感染猪群中有效。

研究设计与样本

  • 研究将38头猪随机分为四组,每组9-10头:NEG(假接种、假攻击)、VAC(PCV2a接种、假攻击)、VAC+CHAL(PCV2a接种并PCV2d攻击)、CHAL(假接种并PCV2d攻击)。
  • 3周龄按标签说明接种Circovac®,7周龄攻击PCV2d,攻击后21天剖检。

主要发现

  • VAC和VAC+CHAL猪在接种后21天血清转阳;攻击时(接种后28天)VAC组3/9、VAC+CHAL组1/9血清阳性;NEG组研究期间保持血清阴性。
  • 与CHAL组相比,VAC+CHAL组在攻击后14和21天病毒血症显著降低,攻击后14和21天粪排毒显著降低,攻击后7、14和21天鼻排毒显著降低。
  • VAC+CHAL组淋巴结平均PCV2抗原载量较CHAL组显著降低。
  • 攻击后21天混合血清或粪便暴露单笼饲养PCV2未感染猪,CHAL组混合粪样含感染性PCV2,VAC+CHAL组则无,提示疫苗接种减少PCV2d传播。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Porcine circovirus type 2 (PCV2) vaccination has been effective in protecting pigs from clinical disease and today is used extensively. Recent studies in vaccinated populations indicate a major PCV2 genotype shift from the predominant PCV2 genotype 2b towards 2d. The aims of this study were to determine the ability of the commercial inactivated PCV2a vaccine Circovac® to protect pigs against experimental challenge with a 2013 PCV2d strain and prevent transmission. Thirty-eight pigs were randomly divided into four groups with 9-10 pigs per group: NEG (sham-vaccinated, sham-challenged), VAC (PCV2a-vaccinated, sham-challenged), VAC+CHAL (PCV2a-vaccinated and PCV2d-challenged), and CHAL (sham-vaccinated, PCV2d-challenged). Vaccination was done at 3weeks of age using Circovac® according to label instructions. The CHAL and VAC+CHAL groups were challenged with PCV2d at 7weeks of age and all pigs were necropsied 21days post-challenge (dpc). The VAC-CHAL pigs seroconverted to PCV2 by 21days post vaccination (dpv). At PCV2d challenge on 28dpv, 3/9 VAC and 1/9 VAC+CHAL pigs were seropositive. NEG pigs remained seronegative for the duration of the study. Vaccination significantly reduced PCV2d viremia (VAC+CHAL) at dpc 14 and 21, PCV2d fecal shedding at dpc 14 and 21 and PCV2d nasal shedding at dpc 7, 14 and 21 compared to CHAL pigs. Vaccination significantly reduced mean PCV2 antigen load in lymph nodes in VAC+CHAL pigs compared to CHAL pigs. When pooled serum or feces collected from VAC+CHAL and CHAL pigs at dpc 21 were used to expose single-housed PCV2 naïve pigs, a pooled fecal sample from CHAL pigs contained infectious PCV2 whereas this was not the case for VAC+CHAL pigs suggesting reduction of PCV2d transmission by vaccination. Under the study conditions, the PCV2a-based vaccine was effective in reducing PCV2d viremia, tissue loads, shedding and transmission indicating that PCV2a vaccination should be effective in PCV2d-infected herds.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Opriessnig T, Xiao CT, Halbur PG, et al. A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naïve pigs under experimental conditions. Vaccine. 2016. PMID: 27919634. doi:10.1016/j.vaccine.2016.11.085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。